176 related articles for article (PubMed ID: 16479139)
1. Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats.
Misugi T; Ozaki K; El Beltagy K; Tokuyama O; Honda K; Ishiko O
Gynecol Obstet Invest; 2006; 61(4):208-15. PubMed ID: 16479139
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y
Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
4. Role of the N, N'-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone.
Sander V; Luchetti CG; Solano ME; Elia E; Di Girolamo G; Gonzalez C; Motta AB
Reproduction; 2006 Mar; 131(3):591-602. PubMed ID: 16514202
[TBL] [Abstract][Full Text] [Related]
5. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ
Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684
[TBL] [Abstract][Full Text] [Related]
6. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.
Sangraula H; Paudel KR; Sharma M
JNMA J Nepal Med Assoc; 2009; 48(176):335-9. PubMed ID: 21105563
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone.
Rezvanfar MA; Rezvanfar MA; Ahmadi A; Saadi HA; Baeeri M; Abdollahi M
Hum Exp Toxicol; 2012 Sep; 31(9):887-97. PubMed ID: 22076494
[TBL] [Abstract][Full Text] [Related]
8. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinediones for treatment of polycystic ovary syndrome.
Stout DL; Fugate SE
Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238
[TBL] [Abstract][Full Text] [Related]
10. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
11. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
Kuscu NK; Koyuncu FM
Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
13. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
Mitkov M; Pehlivanov B; Terzieva D
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):93-8. PubMed ID: 16360262
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance.
Morishita M; Endo T; Baba T; Kuno Y; Ikeda K; Kiya T; Honnma H; Saito T
J Ovarian Res; 2018 Mar; 11(1):24. PubMed ID: 29580285
[TBL] [Abstract][Full Text] [Related]
15. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
Berria R; Gastaldelli A; Lucidi S; Belfort R; De Filippis E; Easton C; Brytzki R; Cusi K; Jovanovic L; DeFronzo R
Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
[TBL] [Abstract][Full Text] [Related]
16. Quercetin modulates granulosa cell mRNA androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in Wistar rats via metabolic and hormonal pathways.
Olaniyan OT; Bamidele O; Adetunji CO; Priscilla B; Femi A; Ayobami D; Okotie G; Oluwaseun I; Olugbenga E; Mali PC
J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32160160
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
Kriplani A; Agarwal N
J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats.
Bas D; Abramovich D; Hernandez F; Tesone M
Cell Biol Int; 2011 May; 35(5):423-9. PubMed ID: 21062263
[TBL] [Abstract][Full Text] [Related]
19. Effects of vitamin D on ovary in DHEA-treated PCOS rat model: A light and electron microscopic study.
Çelik LS; Kuyucu Y; Yenilmez ED; Tuli A; Dağlıoğlu K; Mete UÖ
Ultrastruct Pathol; 2018; 42(1):55-64. PubMed ID: 29192811
[TBL] [Abstract][Full Text] [Related]
20. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
Yilmaz M; Karakoç A; Törüner FB; Cakir N; Tiras B; Ayvaz G; Arslan M
Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]